Sei Investments Co. Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Sei Investments Co. boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 664,676 shares of the company's stock after purchasing an additional 34,307 shares during the quarter. Sei Investments Co. owned about 0.77% of HealthEquity worth $63,776,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in HQY. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity during the 4th quarter valued at $26,000. Smartleaf Asset Management LLC raised its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in HealthEquity in the fourth quarter worth about $39,000. UMB Bank n.a. increased its holdings in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after acquiring an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its position in shares of HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after purchasing an additional 445 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research analyst reports. Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price for the company. KeyCorp decreased their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday. JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a research note on Tuesday. Finally, Wells Fargo & Company increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $113.31.

Remove Ads

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is owned by insiders.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $0.02 on Tuesday, reaching $90.34. The company's stock had a trading volume of 1,209,004 shares, compared to its average volume of 697,297. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a market capitalization of $7.81 billion, a P/E ratio of 82.88, a PEG ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a 50-day moving average price of $104.67 and a 200-day moving average price of $95.84.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.